发明名称 METHODS FOR TREATING DIABETES AND OTHER BLOOD SUGAR DISORDERS
摘要 Compositions, expression vectors and host cells comprising nucleic acid which encodes a precursor glucagon-like peptide 1 (GLP-1) comprising mammalian GLP-1 linked to a heterologous signal sequence are encompassed by the present invention. The invention also relates to a method of promoting insulin production in an individual comprising administering to the individual an effective amount of a nucleic acid encoding a precursor GLP-1. The present invention also relates to a method of treating an individual having a blood sugar defect (e.g., type I or type II diabetes), comprising administering to the individual an effective amount of a nucleic acid encoding the precursor GLP-1. In a particular embodiment, the invention pertains to a method of treating an individual having a blood sugar defect sugar defect comprising administering to the individual an effective amount of a nucleic acid encoding a precursor GLP-1 wherein the precursor GLP-1 comprises a signal sequence which codes for precursor cleavage at the activation cleavage site of the precursor GLP-1.
申请公布号 WO03014318(A2) 申请公布日期 2003.02.20
申请号 WO2002US25227 申请日期 2002.08.07
申请人 GENZYME CORPORATION;WADSWORTH, SAMUEL, C.;ARMENTANO, DONNA;GREGORY, RICHARD, J.;PARSONS, GEOFFREY 发明人 WADSWORTH, SAMUEL, C.;ARMENTANO, DONNA;GREGORY, RICHARD, J.;PARSONS, GEOFFREY
分类号 C12N15/09;A61K31/7088;A61K35/76;A61K38/00;A61K48/00;A61P3/10;A61P5/50;A61P43/00;C07K14/47;C07K14/605;C12N1/15;C12N1/19;C12N1/21;C12N5/10 主分类号 C12N15/09
代理机构 代理人
主权项
地址